Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study
Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual...
Saved in:
Published in | Cancer research and treatment Vol. 53; no. 3; pp. 881 - 888 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Cancer Association
01.07.2021
대한암학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1598-2998 2005-9256 2005-9256 |
DOI | 10.4143/crt.2020.1008 |
Cover
Abstract | Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. |
---|---|
AbstractList | Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access. Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death). A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001). Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Materials and Methods Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).Results A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, ‘a little comfort’ or ‘much comfort’) compared with the usual IV arm (21%) (p <0.001). Conclusion Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. KCI Citation Count: 0 The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.PURPOSEThe purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative care (HPC) unit is acceptable in terms of safety and efficacy and whether it results in superior patient satisfaction compared to usual intravenous (IV) access.Terminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).MATERIALS AND METHODSTerminally ill cancer patients were randomly assigned to two arms: routine PICC access and usual IV access arm. The primary endpoint was IV maintenance success rate, defined as the rate of functional IV maintenance until the intended time (discharge, transfer, or death).A total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001).RESULTSA total of 66 terminally ill cancer patients were enrolled and randomized to study arms. Among them, 57 patients (routine PICC, 29; usual IV, 28) were analyzed. In the routine PICC arm, mean time to PICC was 0.84 days (range, 0 to 3 days), 27 patients maintained PICC with function until the intended time. In the usual IV arm, 11 patients maintained peripheral IV access until the intended time, and 15 patients underwent PICC insertion. The IV maintenance success rate in the routine PICC arm (27/29, 93.1%) was similar to that in the usual IV arm (26/28, 92.8%, p=0.958). Patient satisfaction at day 5 was better in the routine PICC arm (97%, 'a little comfort' or 'much comfort') compared with the usual IV arm (21%) (p <0.001).Routine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit.CONCLUSIONRoutine PICC insertion in terminally ill cancer patients was comparable in safety and efficacy and resulted in superior satisfaction compared with usual IV access. Thus, routine PICC insertion could be considered at admission to the HPC unit. |
Author | Kim, Jae-Joon Park, Kwonoh Jung, Ki Sun Jeon, Ung-Bae Hong, Yun Jeong Oh, Sang-Bo Jang, Joo Yeon Park, Eun Ju Oh, So Yeon Kim, Jin Hyeok |
AuthorAffiliation | 3 Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea 4 Department of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea 2 Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea 1 Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea |
AuthorAffiliation_xml | – name: 4 Department of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea – name: 1 Department of Family Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea – name: 2 Division of Medical Oncology and Hematology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea – name: 3 Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea |
Author_xml | – sequence: 1 givenname: Eun Ju surname: Park fullname: Park, Eun Ju – sequence: 2 givenname: Kwonoh surname: Park fullname: Park, Kwonoh – sequence: 3 givenname: Jae-Joon surname: Kim fullname: Kim, Jae-Joon – sequence: 4 givenname: Sang-Bo surname: Oh fullname: Oh, Sang-Bo – sequence: 5 givenname: Ki Sun surname: Jung fullname: Jung, Ki Sun – sequence: 6 givenname: So Yeon surname: Oh fullname: Oh, So Yeon – sequence: 7 givenname: Yun Jeong surname: Hong fullname: Hong, Yun Jeong – sequence: 8 givenname: Jin Hyeok surname: Kim fullname: Kim, Jin Hyeok – sequence: 9 givenname: Joo Yeon surname: Jang fullname: Jang, Joo Yeon – sequence: 10 givenname: Ung-Bae surname: Jeon fullname: Jeon, Ung-Bae |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33355838$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738775$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1kk1vEzEQhi1URNPCkSvyESQ2-Gs3aw5IUdTCSpWImvRsOd5ZYrrrDbZTFP5f_xfebFsBEqexZp55ZzR-z9CJ6x0g9JqSqaCCfzA-ThlhZEoJKZ-hCSMkzyTLixM0obksMyZleYrOQvhOSCH4jL5Ap5zzPC95OUH3K91APLzHF01jjTbppV2NlzpacBGvUgyNNtH2Dv-0cYsrZ6PVLV6Ct7steN22h5QM4CPUeJGaUgovdNxCBB_wou922qfSsfsm7FO1GqA7cP0-4LkxEAK2Dq_Bd9aNeu0g4Qz4x03CRzzH12m1vrO_ktpyqwPgqsKruK8PL9HzRrcBXj3Ec3RzebFefMmuvn6uFvOrzLCiKLMGgDFebBrJGakLLQpSbwQtmSAFJRsqcyKJZqyQG6mJaDTTNZMmHYvrkqWjnaN3o67zjbo1VvXaHuO3Xt16Nb9eV0qWQjA6S-ynkd3tNx3UZryM2nnbaX84dv5dcXabdO5UySSlUiSBtw8Cvv-xhxBVZ4OBttUO0uUUEzMuKGF8QN_8OetpyOM_JyAbAeP7EDw0TwglavCRSj5Sg4_U4KPE8394Y6MeXJBWte1_un4D7ajOQQ |
CitedBy_id | crossref_primary_10_1186_s12885_024_12099_8 crossref_primary_10_1177_10499091241252977 crossref_primary_10_17479_jacs_2024_14_1_9 crossref_primary_10_1007_s00520_021_06293_8 crossref_primary_10_1016_j_jpedsurg_2024_02_022 crossref_primary_10_3390_cancers15194712 crossref_primary_10_1177_10547738231194099 crossref_primary_10_1038_s41598_021_91749_4 crossref_primary_10_3390_cancers15041338 crossref_primary_10_5758_vsi_220054 crossref_primary_10_1007_s00520_024_08664_3 crossref_primary_10_1007_s00520_023_08045_2 crossref_primary_10_1177_10547738241260947 |
Cites_doi | 10.4065/72.3.225 10.1007/s00520-016-3360-6 10.1007/s00520-005-0886-4 10.7326/0003-4819-132-5-200003070-00009 10.1111/j.1444-0903.2004.00447.x 10.1056/nejmra011883 10.1200/jco.2002.11.135 10.4143/crt.2013.148 10.1016/j.jpainsymman.2009.11.327 10.1089/sur.2008.058 10.1053/srao.2000.6590 10.14475/kjhpc.2014.17.3.179 10.1111/j.1365-2354.2006.00664.x |
ContentType | Journal Article |
Copyright | Copyright © 2021 by the Korean Cancer Association 2021 |
Copyright_xml | – notice: Copyright © 2021 by the Korean Cancer Association 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.4143/crt.2020.1008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-9256 |
EndPage | 888 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9844217 PMC8291194 33355838 10_4143_crt_2020_1008 |
Genre | Randomized Controlled Trial Clinical Trial, Phase II Journal Article |
GrantInformation_xml | – fundername: Pusan National University Hospital grantid: 30-2017-004 |
GroupedDBID | --- 29B 5-W 53G 8JR 9ZL AAYXX ABDBF ACUHS ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EBD EF. F5P HYE OK1 RPM TR2 C1A CGR CUY CVF ECM EIF NPM 7X8 5PM 08R M~E |
ID | FETCH-LOGICAL-c2668-fee2236bf9320d6a460db418240610b195090a2269b9a04fa2ad29c3353a82333 |
ISSN | 1598-2998 2005-9256 |
IngestDate | Tue Nov 21 21:35:44 EST 2023 Thu Aug 21 14:32:11 EDT 2025 Fri Jul 11 07:50:30 EDT 2025 Thu Apr 03 06:59:54 EDT 2025 Thu Apr 24 23:10:58 EDT 2025 Tue Jul 01 03:18:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Palliative care Terminally ill cancer patients Peripherally inserted central catheter |
Language | English |
License | This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2668-fee2236bf9320d6a460db418240610b195090a2269b9a04fa2ad29c3353a82333 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 This study was presented in part at the ESMO Virtual Congress 2020, 19 September–21 September 2020. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8291194 |
PMID | 33355838 |
PQID | 2473410234 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9844217 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8291194 proquest_miscellaneous_2473410234 pubmed_primary_33355838 crossref_primary_10_4143_crt_2020_1008 crossref_citationtrail_10_4143_crt_2020_1008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-Jul |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-Jul |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Cancer research and treatment |
PublicationTitleAlternate | Cancer Res Treat |
PublicationYear | 2021 |
Publisher | Korean Cancer Association 대한암학회 |
Publisher_xml | – name: Korean Cancer Association – name: 대한암학회 |
References | ref13 ref12 ref14 ref11 ref10 ref2 ref1 ref8 ref7 ref9 ref4 ref3 Llobera (ref6) 2000 ref5 |
References_xml | – start-page: 2036 volume-title: Terminal cancer. duration and prediction of survival time year: 2000 ident: ref6 – ident: ref3 doi: 10.4065/72.3.225 – ident: ref7 doi: 10.1007/s00520-016-3360-6 – ident: ref4 doi: 10.1007/s00520-005-0886-4 – ident: ref14 doi: 10.7326/0003-4819-132-5-200003070-00009 – ident: ref12 doi: 10.1111/j.1444-0903.2004.00447.x – ident: ref10 doi: 10.1056/nejmra011883 – ident: ref2 doi: 10.1200/jco.2002.11.135 – ident: ref5 doi: 10.4143/crt.2013.148 – ident: ref9 doi: 10.1016/j.jpainsymman.2009.11.327 – ident: ref11 doi: 10.1089/sur.2008.058 – ident: ref1 doi: 10.1053/srao.2000.6590 – ident: ref8 doi: 10.14475/kjhpc.2014.17.3.179 – ident: ref13 doi: 10.1111/j.1365-2354.2006.00664.x |
SSID | ssj0064371 |
Score | 2.2025466 |
Snippet | Purpose The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a... The purpose of this study was to investigate whether routine insertion of peripherally inserted central catheter (PICC) at admission to a hospice-palliative... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 881 |
SubjectTerms | Administration, Intravenous - adverse effects Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Catheterization, Peripheral - adverse effects Catheterization, Peripheral - psychology Catheterization, Peripheral - statistics & numerical data Female Hospices - statistics & numerical data Humans Male Middle Aged Neoplasms - drug therapy Neoplasms - psychology Original Palliative Care - methods Palliative Care - psychology Palliative Care - statistics & numerical data Patient Satisfaction - statistics & numerical data Prospective Studies Terminal Care - methods Terminal Care - psychology Terminal Care - statistics & numerical data Terminally Ill - psychology Terminally Ill - statistics & numerical data Treatment Outcome 의학일반 |
Title | Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33355838 https://www.proquest.com/docview/2473410234 https://pubmed.ncbi.nlm.nih.gov/PMC8291194 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738775 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Cancer Research and Treatment, 2021, 53(3), , pp.881-888 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9owFLZKK1V9mbo7u8mbpr1AupAYkuwNOqrC1A2tIPUtcoIpqDSpAmhq_9_-187xJRfUSVtfuORim5wP-xz783cI-SimPo9g5LO46HQsxmLXgj7Pxa_tOPIcXM1BtsX3zumEDS_aFzu1wxJrabOOjuK7e_eVPMSqcAzsirtk_8OyeaFwAD6DfeEVLAyv_2Tjcz4TStS_j0oQPL41ZMyRkkttnJc2L6g51wGyhcAuI2iglBRYLm-RMiCydTHZqzYGovCm6jBykvpktZHiHGvMWiTVXbsy4yJOm4wVr0aWt8QiAE-ZaclKbYH_CY1Lrxd3UN5oDgNoYzCQVMbK4rK-U-sQqa13OSG-WPNSJO_-JmkMN9tHv_1KkzSf6dYpo4dcWMO04B38mKs58eTS6qXl6Q-nlVNl9WaCNMMVC92wbUjrPj3AjSYq2fWRkMekAGvgKE1zMxAo1WINeLfUq_sqq4xxEFQewu2xh4HnCYCJM2ToOpJ-UrkOHvPNtQSi66KmvesXQ3BOjBydHfsOjD8Bq5E9x_OQebDX7X3tnRj3AhdalQiw_lVKOBZr_1yp-4Dsm4oqPlctyWb3hVPbrOCSmzU-JI90fES7CuyPyY5InpD9M80AeUp-K8w3qUF8kwI8qEYZLeOdImKpxjst450avFONd5rjnRq8q7sl3mkJ71ThnS4SWuCdAt6pAodpyeoL7dIC7VSinQ4GVKL9GZmc9MfHp5ZORWLF4MH61kwI8KM70QzCHXva4axjTyMGsTn6w3aEuZQDm0MoE0QBt9mMO3zqBDE8f5f7DtjhOdlN0kS8JDQCbxCiHDzXYj53olbMbBFz0fY5hGdxnTSNscJY6_RjuphlCPE6mjkEM4doZtQb9-vkU375jRKo-duFH8Dy4VW8CFFSHt8v0_AqCyFwHoSBz5jT8urkvQFGCOMMLh7yRMDTDR3mgcMLHj6rkxcKKHl9Bmd14lUglF-AFVbPJIu51LLXaH_14Dtfk4OiW3hDdtfZRryFOGEdvdP_nD8Eixi9 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety%2C+Efficacy%2C+and+Patient+Satisfaction+with+Initial+Peripherally+Inserted+Central+Catheters+Compared+with+Usual+Intravenous+Access+in+Terminally+Ill+Cancer+Patients%3A+A+Randomized+Phase+II+Study&rft.jtitle=Cancer+research+and+treatment&rft.au=Park%2C+Eun+Ju&rft.au=Park%2C+Kwonoh&rft.au=Kim%2C+Jae-Joon&rft.au=Oh%2C+Sang-Bo&rft.date=2021-07-01&rft.pub=Korean+Cancer+Association&rft.issn=1598-2998&rft.eissn=2005-9256&rft.volume=53&rft.issue=3&rft.spage=881&rft.epage=888&rft_id=info:doi/10.4143%2Fcrt.2020.1008&rft_id=info%3Apmid%2F33355838&rft.externalDocID=PMC8291194 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon |